Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Kunihito Arai"'
Autor:
Masahiro Sakaguchi, Nana Nakajima, Hiroki Yamaguchi, Yuho Najima, Katsuhiro Shono, Atsushi Marumo, Ikuko Omori, Yusuke Fujiwara, Kazuki Terada, Shunsuke Yui, Satoshi Wakita, Miho Mitaya, Kunihito Arai, Tomoaki Kitano, Noriko Doki, Kazuteru Ohashi, Koiti Inokuchi
Publikováno v:
Leukemia Research Reports, Vol 13, Iss , Pp 100198- (2020)
Fms-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) is a key predictive factor for the prognosis of acute myeloid leukemia (AML). We compared the detection sensitivity of fragment analysis with that of PCR-electrophoresis using MV4-11 (
Externí odkaz:
https://doaj.org/article/83de8e6f78e142848c9d98dcfaf08594
Autor:
Takeshi Ryotokuji, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Saiko Kurosawa, Yutaka Kobayashi, Eri Kawata, Kenji Tajika, Seiji Gomi, Junya Kanda, Anna Kobayashi, Ikuko Omori, Atsushi Marumo, Yusuke Fujiwara, Shunsuke Yui, Kazuki Terada, Keiko Fukunaga, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Fumiko Kosaka, Hayato Tamai, Kazutaka Nakayama, Satoshi Wakita, Takahiro Fukuda, Koiti Inokuchi
Publikováno v:
Haematologica, Vol 101, Iss 9 (2016)
In recent years, it has been reported that the frequency of DNA-methylation regulatory gene mutations – mutations of the genes that regulate gene expression through DNA methylation – is high in acute myeloid leukemia. The objective of the present
Externí odkaz:
https://doaj.org/article/cb880013303b4206a27de053b4357c0a
Autor:
Kunihito Arai1, Masahiro Sakaguchi1 m-sakaguchi@nms.ac.jp, Shunsuke Yui1, Tomoaki Kitano1, Miho Miyata1, Mayumi Yogosawa1, Kazutaka Nakayama2, Kenji Tajika2, Kensuke Usuki3, Junya Kuroda4, Nobuhiko Uoshima5, Yutaka Kobayashi5, Hitoji Uchiyama6, Yasushi Kubota7, Shinya Kimura7, Shinichiro Mori8, Mitsuharu Hirai9, Satoshi Wakita1, Hiroki Yamaguchi1
Publikováno v:
International Journal of Laboratory Hematology. Dec2022, Vol. 44 Issue 6, p1102-1110. 9p.
Autor:
Satoshi Wakita, Atsushi Marumo, Kaoru Morita, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Naoyuki Uchida, Yasushi Kubota, Shinya Kimura, Hisao Nagoshi, Tatsuo Ichinohe, Saiko Kurosawa, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Haruka Arai, Masayuki Kanda, Kako Itabashi, Takahiro Fukuda, Yoshinobu Kanda, Hiroki Yamaguchi
Publikováno v:
Cancer Science. 114:1297-1308
Nucleophosmin1 (NPM1) mutations are the most frequently detected gene mutations in acute myeloid leukemia (AML) and are considered a favorable prognostic factor. We retrospectively analyzed the prognosis of 605 Japanese patients with de novo AML, inc
Autor:
Kunihito Arai, Masahiro Sakaguchi, Shunsuke Yui, Tomoaki Kitano, Miho Miyata, Mayumi Yogosawa, Kazutaka Nakayama, Kenji Tajika, Kensuke Usuki, Junya Kuroda, Nobuhiko Uoshima, Yutaka Kobayashi, Hitoji Uchiyama, Yasushi Kubota, Shinya Kimura, Shinichiro Mori, Mitsuharu Hirai, Satoshi Wakita, Hiroki Yamaguchi
Publikováno v:
International Journal of Laboratory Hematology. 44:1102-1110
Autor:
Atsushi Marumo, Satoshi Wakita, Kaoru Morita, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shin-Ichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Naoyuki Uchida, Yasushi Kubota, Shinya Kimura, Hisao Nagoshi, Tatsuo Ichinohe, Saiko Kurosawa, Sayuri Motomura, Hashimoto Akiko, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Takahiro Fukuda, Yoshinobu Kanda, Hiroki Yamaguchi
Publikováno v:
Blood. 140:8914-8916
Autor:
Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori, Ryosuke Kinoshita, Daishi Onai, Mika Sunakawa, Yuta Kaito, Kazuki Inai, Taichiro Tokura, Atsushi Takeyoshi, Shunichi Yasuda, Shunsuke Honma, Kazutaka Nakayama, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Muneo Okamoto, Koiti Inokuchi, Hiroki Yamaguchi
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 19:136-148
The MEAM regimen consisting of ranimustine (MCNU), etoposide (ETP), cytarabine (Ara-C), and melphalan (MEL) is widely used before auto-peripheral blood stem cell transplantation (auto-PBSCT) for malignant lymphoma in Japan. The MEAM regimen generally
Autor:
Atsushi Marumo, Satoshi Wakita, Kaoru Morita, Iekuni Oh, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Yasushi Kubota, Shinya Kimura, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Kenta Date, Yusuke Fujiwara, Kazuki Terada, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Kazuteru Ohashi, Yoshinobu Kanda, Hiroki Yamaguchi
Publikováno v:
International Journal of Hematology. 116:199-214
Recent studies have reported that measurable residual disease (MRD) analysis using NPM1 mutations helps determine whether allogeneic hematopoietic stem cell transplantation (allo-HSCT) is indicated in acute myeloid leukemia (AML) patients. However, t
Autor:
Ayumi Mizoguchi, Atsushi Marumo, Nobuhiko Uoshima, Eriko Sato, Satoshi Wakita, Hiroki Yamaguchi, Eri Kawata, Kenji Tajika, Jiro Tadokoro, Yuhei Nagao, Tomoaki Kitano, Iekuni Oh, Kunihito Arai, Yasushi Kubota, Shinichi Kako, Ikuko Omori, Hisao Nagoshi, Shinichiro Mori, Koiti Inokuchi, Yoshinobu Kanda, Sayuri Motomura, Naoyuki Uchida, Yutaka Kobayashi, Hideharu Muto, Junya Kuroda, Toshimitsu Ueki, Miho Miyata, Noriko Doki, Saiko Kurosawa, Masao Ogata, Takahiro Fukuda, Norio Komatsu, Kenjiro Mitsuhashi, Takashi Toya, Jun Ando, Shinya Kimura, Katsuhiro Shono, Hitoji Uchiyama, Kazuki Terada, Masao Hagihara, Kensuke Kayamori, Atsushi Satake, Kazuteru Ohashi, Kensuke Usuki, Akiko Hashimoto, Akiyo Kurosawa, Junya Kanda, Shunsuke Yui, Motoharu Shibusawa, Yusuke Fujiwara, Yuho Najima, Tatsuo Ichinohe, Masahiro Sakaguchi
Publikováno v:
Blood Advances
Key Points CEBPA mutation in the bZIP domain is associated with favorable prognosis in de novo AML, even if it was detected as CEBPAsm.
Visual Abstract
Mutations of CCAAT/enhancer–binding protein alpha (CEBPAmu) are found in 10% to 15% of
Visual Abstract
Mutations of CCAAT/enhancer–binding protein alpha (CEBPAmu) are found in 10% to 15% of
Autor:
Kunihito Arai, Saiko Kurosawa, Yoshinobu Kanda, Yuho Najima, Yasushi Kubota, Kenji Tajika, Atsushi Marumo, Toshimitsu Ueki, Iekuni Oh, Yusuke Fujiwara, Masahiro Sakaguchi, Shinichi Kako, Kazuhiko Kakihana, Hitoji Uchiyama, Junya Kanda, Kensuke Usuki, Shunsuke Yui, Katsuhiro Shono, Masao Hagihara, Kazuteru Ohashi, Takahiro Fukuda, Satoshi Wakita, Hiroki Yamaguchi, Kensuke Kayamori, S Mori, Yutaka Kobayashi, Tomoaki Kitano, Naoyuki Uchida, Ikuko Omori, Shinya Kimura, Eri Kawata, Nobuhiko Uoshima, Koiti Inokuchi, Seiji Gomi, Junya Kuroda, Nana Nakajima
Publikováno v:
Blood Advances. 2:2744-2754
In the opinion of the European LeukemiaNet (ELN), nucleophosmin member 1 gene mutation (NPM1 mut)–positive acute myeloid leukemia (AML) with an fms-like kinase 3-internal tandem duplication (FLT3-ITD) allele ratio (AR)